gradiant.co.krCrawled Nov 16, 2026
Gradient contributes to human health through innovative biotech in its healthcare business.
Gradient invests in technology sectors to create new growth opportunities.
Gradient builds a knowledge platform to connect and share scientific knowledge with the public.
Gradient shares company news.
Gradient seeks creative and passionate talent to lead new business trends.
Gradient fosters growth for employees and the company through fair personnel policies.
Gradient’s employees combine passion and expertise to create new value and shape the future.
The page provides a channel for reporting misconduct.
iMarketKorea has expanded from selling small industrial components like bolts to operating an **858,000-square-meter industrial park**, positioning itself as a comprehensive B2B platform for manufacturers. The company connects suppliers and buyers of raw materials, machinery parts, and factory operations essentials across global markets. Its growth reflects a long-term strategy to consolidate industrial procurement under one digital ecosystem.
Sep 2026The Herald BusinessNews article
Gradiant, led by founder Lee Ki-hyung, is transitioning its focus from drug development to offering biotech services. The company now emphasizes Organoid-based contract research (CRO) and in vitro diagnostics as part of its new strategy. This shift follows the dissolution of its drug development subsidiary, Therapex.
Apr 2026ChosunbizNews article
Strand Therapeutics secures **$153 million in Series B funding** to advance its **mRNA-based therapeutics**. The Boston-based biotech company focuses on developing novel treatments using mRNA technology, a platform gaining traction in drug development.
Aug 2025FinSMEsNews article
Grove Biopharma secures $30 million in Series A funding to advance its biotechnology initiatives. The Chicago-based company leverages the capital to support research and development in its core focus areas. This funding round highlights growing investor confidence in Grove Biopharma’s potential.
Apr 2025FinSMEsNews article